The effect of preoperative dexmedetomidine use and acute kidney injury in pediatric patients with congenital heart disease undergoing open cardiac surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130816014372N10

Enrollment

Registered

2019-04-26

Start date

2019-05-25

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital heart disease. Congenital malformation of heart, unspecified

Interventions

Intervention 1: Intervention group: In the group (D), 0.4 µg / kg / hr. of dexmedetomidine infusion were administered after anesthesia induction until the end of the operation. Intervention 2: Control

Eligibility

Sex/Gender

All

Age

6 Months to 8 Years

Inclusion criteria

Inclusion criteria: children aged 6 months to 8 years congenital heart disease Children who are candidates for open heart surgery

Exclusion criteria

Exclusion criteria: Emergency operation Re-do Operation heart failure preoperative renal failure (Serum Cr> 2 mg / dl Liver failure Use of inotropic or vasopressor prior to surgery Need Deep hypothermic circulatory arrest during surgery

Design outcomes

Primary

Measure	Time frame
Inotrope Score. Timepoint: Intra-operatively and 3 days after operation. Method of measurement: Inotrope Score (IS)Vasoactive – inotropic score (VIS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSheema Eskandari

Shiraz University of Medical Sciences

eskandari.sheema@yahoo.com+98 36474270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026